Literature DB >> 26354812

Infection with Toxin A-Negative, Toxin B-Negative, Binary Toxin-Positive Clostridium difficile in a Young Patient with Ulcerative Colitis.

Grace O Androga1, Julie Hart2, Niki F Foster3, Adrian Charles4, David Forbes5, Thomas V Riley6.   

Abstract

Large clostridial toxin-negative, binary toxin-positive (A(-) B(-) CDT(+)) strains of Clostridium difficile are almost never associated with clinically significant C. difficile infection (CDI), possibly because such strains are not detected by most diagnostic methods. We report the isolation of an A(-) B(-) CDT(+) ribotype 033 (RT033) strain of C. difficile from a young patient with ulcerative colitis and severe diarrhea.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26354812      PMCID： PMC4609731          DOI： 10.1128/JCM.01810-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  13 in total

1.  Evaluation of the Cepheid Xpert C. difficile/Epi and meridian bioscience illumigene C. difficile assays for detecting Clostridium difficile ribotype 033 strains.

Authors:  Grace O Androga; Alan M McGovern; Briony Elliott; Barbara J Chang; Timothy T Perkins; Niki F Foster; Thomas V Riley
Journal:  J Clin Microbiol       Date:  2014-12-17       Impact factor: 5.948

2.  Clostridium difficile infection in Europe: a hospital-based survey.

Authors:  Martijn P Bauer; Daan W Notermans; Birgit H B van Benthem; Jon S Brazier; Mark H Wilcox; Maja Rupnik; Dominique L Monnet; Jaap T van Dissel; Ed J Kuijper
Journal:  Lancet       Date:  2011-01-01       Impact factor: 79.321

Review 3.  Clostridium difficile infection and inflammatory bowel disease.

Authors:  Camelia Cojocariu; Carol Stanciu; Oana Stoica; Ana Maria Singeap; Catalin Sfarti; Irina Girleanu; Anca Trifan
Journal:  Turk J Gastroenterol       Date:  2014-12       Impact factor: 1.852

4.  Nationwide surveillance study of Clostridium difficile in Australian neonatal pigs shows high prevalence and heterogeneity of PCR ribotypes.

Authors:  Daniel R Knight; Michele M Squire; Thomas V Riley
Journal:  Appl Environ Microbiol       Date:  2014-10-17       Impact factor: 4.792

Review 5.  Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.

Authors:  Orna Nitzan; Mazen Elias; Bibiana Chazan; Raul Raz; Walid Saliba
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

6.  Surveillance for antimicrobial resistance in Australian isolates of Clostridium difficile, 2013-14.

Authors:  Daniel R Knight; Steven Giglio; Peter G Huntington; Tony M Korman; Despina Kotsanas; Casey V Moore; David L Paterson; Louise Prendergast; Charlotte A Huber; Jennifer Robson; Lynette Waring; Michael C Wehrhahn; Gerhard F Weldhagen; Richard M Wilson; Thomas V Riley
Journal:  J Antimicrob Chemother       Date:  2015-07-28       Impact factor: 5.790

7.  Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain.

Authors:  M R Popoff; E J Rubin; D M Gill; P Boquet
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

8.  Cross-sectional study reveals high prevalence of Clostridium difficile non-PCR ribotype 078 strains in Australian veal calves at slaughter.

Authors:  Daniel R Knight; Sara Thean; Papanin Putsathit; Stan Fenwick; Thomas V Riley
Journal:  Appl Environ Microbiol       Date:  2013-02-08       Impact factor: 4.792

9.  Prevalence and pathogenicity of binary toxin-positive Clostridium difficile strains that do not produce toxins A and B.

Authors:  C Eckert; A Emirian; A Le Monnier; L Cathala; H De Montclos; J Goret; P Berger; A Petit; A De Chevigny; H Jean-Pierre; B Nebbad; S Camiade; R Meckenstock; V Lalande; H Marchandin; F Barbut
Journal:  New Microbes New Infect       Date:  2014-11-08

10.  Relationship between bacterial strain type, host biomarkers, and mortality in Clostridium difficile infection.

Authors:  A Sarah Walker; David W Eyre; David H Wyllie; Kate E Dingle; David Griffiths; Brian Shine; Sarah Oakley; Lily O'Connor; John Finney; Alison Vaughan; Derrick W Crook; Mark H Wilcox; Tim E A Peto
Journal:  Clin Infect Dis       Date:  2013-03-05       Impact factor: 20.999
View more
  10 in total

Review 1.  Clostridium difficile infection.

Authors:  Wiep Klaas Smits; Dena Lyras; D Borden Lacy; Mark H Wilcox; Ed J Kuijper
Journal:  Nat Rev Dis Primers       Date:  2016-04-07       Impact factor: 52.329

Review 2.  The role of toxins in Clostridium difficile infection.

Authors:  Ramyavardhanee Chandrasekaran; D Borden Lacy
Journal:  FEMS Microbiol Rev       Date:  2017-11-01       Impact factor: 16.408

Review 3.  An Update on Clostridioides difficile Binary Toxin.

Authors:  Adrián Martínez-Meléndez; Flora Cruz-López; Rayo Morfin-Otero; Héctor J Maldonado-Garza; Elvira Garza-González
Journal:  Toxins (Basel)       Date:  2022-04-27       Impact factor: 5.075

Review 4.  Current knowledge on the laboratory diagnosis of Clostridium difficile infection.

Authors:  Adrián Martínez-Meléndez; Adrián Camacho-Ortiz; Rayo Morfin-Otero; Héctor Jesús Maldonado-Garza; Licet Villarreal-Treviño; Elvira Garza-González
Journal:  World J Gastroenterol       Date:  2017-03-07       Impact factor: 5.742

5.  Host-targeted niclosamide inhibits C. difficile virulence and prevents disease in mice without disrupting the gut microbiota.

Authors:  John Tam; Therwa Hamza; Bing Ma; Kevin Chen; Greg L Beilhartz; Jacques Ravel; Hanping Feng; Roman A Melnyk
Journal:  Nat Commun       Date:  2018-12-07       Impact factor: 14.919

6.  Phosphorylation and functionality of CdtR in Clostridium difficile.

Authors:  T W Bilverstone; N P Minton; S A Kuehne
Journal:  Anaerobe       Date:  2019-07-16       Impact factor: 3.331

7.  Prevalence of binary toxin positive Clostridium difficile in diarrhoeal humans in the absence of epidemic ribotype 027.

Authors:  Alan M McGovern; Grace O Androga; Daniel R Knight; Mark W Watson; Briony Elliott; Niki F Foster; Barbara J Chang; Thomas V Riley
Journal:  PLoS One       Date:  2017-11-08       Impact factor: 3.240

Review 8.  Gut Microbiota and Diarrhea: An Updated Review.

Authors:  Yunxia Li; Siting Xia; Xiaohan Jiang; Can Feng; Saiming Gong; Jie Ma; Zhengfeng Fang; Jie Yin; Yulong Yin
Journal:  Front Cell Infect Microbiol       Date:  2021-04-15       Impact factor: 5.293

9.  Frontiers in antibiotic alternatives for Clostridioides difficile infection.

Authors:  Matthew Phanchana; Phurt Harnvoravongchai; Supapit Wongkuna; Tanaporn Phetruen; Wichuda Phothichaisri; Supakan Panturat; Methinee Pipatthana; Sitthivut Charoensutthivarakul; Surang Chankhamhaengdecha; Tavan Janvilisri
Journal:  World J Gastroenterol       Date:  2021-11-14       Impact factor: 5.742

Review 10.  Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.

Authors:  Deirdre A Collins; Thomas V Riley
Journal:  Lett Appl Microbiol       Date:  2022-02-11       Impact factor: 2.813
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.